window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Uncategorised

  • Uncategorised

    Longitude Prize on ALS awards £2m to AI drug discovery teams

    The Longitude Prize on ALS has awarded £2 million to [...]

    May 7, 2026
  • Uncategorised

    Outpost Bio raises $3.5M pre-seed to build AI models of human microbiology

    Outpost Bio has raised $3.5m in a pre-seed round to [...]

    March 3, 2026
  • Uncategorised

    MaaT Pharma randomizes first patient in IMMUNOLIFE Phase 2 NSCLC microbiome study

    MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]

    January 21, 2026
  • Uncategorised

    Prosper AI raises $5M to expand AI-driven healthcare voice platform

    Artificial intelligence is reshaping the pharmaceutical and healthcare industries, accelerating [...]

    October 3, 2025
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Uncategorised

    CPHI Frankfurt 2025 set to welcome more than 60,000 global pharma professionals

    CPHI Frankfurt 2025 will bring the world’s pharmaceutical community back [...]

    May 5, 2026
  • Uncategorised

    Camena Bioscience and Constructive Bio team up in £9.1m project to build synthetic plant genomes

    Two UK-based innovators, Camena Bioscience and Constructive Bio, have joined [...]

    August 15, 2025
  • Uncategorised

    FDA clears Daxor’s next-generation blood volume analyzer for precise fluid management

    Daxor Corporation, a global leader in blood volume measurement technology, [...]

    August 8, 2025
  • Clinical & Regulatory,Manufacturing & Supply Chain,Uncategorised

    Cherwell to become AnalytiChem UK from September 2025

    Cleanroom microbiology solutions specialist Cherwell is set to be renamed [...]

    May 5, 2026
  • Uncategorised

    Pharvaris eyes 2026 filing as Phase 3 HAE trial timeline shifts

    Pharvaris has adjusted its guidance for topline results from its [...]

    July 10, 2025
  • Uncategorised

    Actithera raises $75.5M to advance precision radioligand therapies targeting difficult-to-drug tumors

    Oversubscribed Series A financing led by M Ventures, Hadean, Sofinnova [...]

    July 9, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Turning AI Skeptics into AI Advocates Through High-Integrity Data
    Categories: Biotech & Pharma Business, Digital & Data
  • AstraZeneca’s Imfinzi recommended by NICE for resectable gastric and gastro-oesophageal junction cancer
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • Grow Therapy study finds most patients report meaningful improvement in depression and anxiety symptoms
    Categories: Clinical & Regulatory, Digital & Data, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top